[Inhibitors of corticosteroid formation. I. The first adrenal cortex inhibitors].
D000305:Adrenal Cortex Hormones / Q000037:antagonists & inhibitors*; D000310:Adrenal Gland Neoplasms / Q000188:drug therapy*; D000311:Adrenal Glands / Q000187:drug effects*; D000308:Adrenocortical Hyperfunction / Q000188:drug therapy*; D000924:Anticholesteremic Agents / Q000494:pharmacology; D002074:Butanones / Q000494:pharmacology; D006496:Heparinoids / Q000494:pharmacology; D006801:Humans; D006846:Hydrocarbons, Halogenated / Q000494:pharmacology; D007192:Indenes / Q000494:pharmacology; D008797:Metyrapone / Q000494:pharmacology; D000451:Mineralocorticoid Receptor Antagonists; D009281:Naphthalenes / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000924:Anticholesteremic Agents; D002074:Butanones; D006496:Heparinoids; D006846:Hydrocarbons, Halogenated; D007192:Indenes; D000451:Mineralocorticoid Receptor Antagonists; D009281:Naphthalenes; D008797:Metyrapone
Les inhibiteurs de la cortico-stéroidogenèse. I. Les premiers inhibiteurs cortico-surrénaliens.